Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / MED BREAKTHGH
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
1.21M
-
Shares change
-
-13.2K
-
Total reported value, excl. options
-
$39.9M
-
Value change
-
-$270K
-
Put/Call ratio
-
0.53
-
Number of buys
-
10
-
Number of sells
-
-19
-
Price
-
$32.94
Significant Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q4 2023
43 filings reported holding SBIO - ALPS ETF TR - MED BREAKTHGH as of Q4 2023.
ALPS ETF TR - MED BREAKTHGH (SBIO) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.21M shares
.
Largest 10 shareholders include DAVENPORT & Co LLC (688K shares), BANK OF AMERICA CORP /DE/ (152K shares), MORGAN STANLEY (85.6K shares), WELLS FARGO & COMPANY/MN (80.6K shares), UBS Group AG (77.8K shares), NTV ASSET MANAGEMENT LLC (32.7K shares), Strategic Financial Services, Inc, (19.9K shares), LPL Financial LLC (19.5K shares), CITADEL ADVISORS LLC (18.7K shares), and GTS SECURITIES LLC (17.9K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.